A Homozygous Variant in HSD17B1 Identified in Women With Poor Ovarian Response

被引:0
|
作者
Ren, Jingyi [1 ]
Ouyang, Yan [1 ,2 ]
Wang, Shuangyao [1 ]
Gong, Fei [1 ,2 ]
Lu, Guangxiu [1 ,2 ]
Lin, Ge [1 ,2 ]
Guo, Jing [1 ,2 ]
机构
[1] Cent South Univ, Sch Basic Med Sci, NHC Key Lab Human Stem Cell & Reprod Engn, Changsha, Peoples R China
[2] Reprod & Genet Hosp CITIC Xiangya, Clin Res Ctr Reprod & Genet Hunan Prov, Changsha, Peoples R China
关键词
female infertility; follicle development; POR; HSD17B1;
D O I
10.1111/cge.14707
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
An increasing number of patients utilizing in vitro fertilization (IVF) and assisted reproductive technology (ART) are characterized as impaired or poor ovarian responders (PORs). Owing to its unclear molecular etiology, the management of patients with age-related ovarian characteristics remains a controversial and complex clinical concern. Therefore, it is important to identify and understand the etiological causes behind POR to develop more effective and efficient management strategies for these patients. In this study, we report a homozygous HSD17B1 (accession number: NM_000413.4) variant (c.718-1G>C) in a patient with POR from a consanguineous family. The proband, a 33-years-old woman, exhibited poor ovarian reserve prestimulation parameters (antral follicle count < 5; anti-M & uuml;llerian hormone = 0.386 ng/mL), resulting in the classification of this patient as patient oriented strategies encompassing individualized oocyte number (POSEIDON) group three according to the POSEIDON criteria. Additionally, this patient displayed impaired estradiol production and reduced 17-ketosteroids secretion and multiple ovarian cysts, which differed from previously reported POR cases. Overall, our findings provide valuable insights for researchers and clinicians into the relationships between the phenotype and genotype of POR and the HSD17B1 gene.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Polymorphisms in CYP19A1, HSD17B1 and HSD17B2 genes and serum. sex hormone level among postmenopausal Japanese women
    Hosono, Satoyo
    Ito, Hidemi
    Oze, Isao
    Higaki, Yasuki
    Morita, Emi
    Takashima, Naoyuki
    Suzuki, Sadao
    Shimatani, Keiichi
    Mikami, Haruo
    Ohnaka, Keizo
    Ozaki, Etsuko
    Katsuura-Kamano, Sakurako
    Kubo, Michiaki
    Nagata, Chisato
    Naito, Mariko
    Hamajima, Nobuyuki
    Tanaka, Hideo
    MATURITAS, 2015, 82 (04) : 394 - 401
  • [22] Amplification of HSD17B1 and ERBB2 in primary breast cancer
    Gunnarsson, C
    Ahnström, M
    Kirschner, K
    Olsson, B
    Nordenskjöld, B
    Rutqvist, LE
    Skoog, L
    Stål, O
    ONCOGENE, 2003, 22 (01) : 34 - 40
  • [23] Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer
    Cecilia Gunnarsson
    Piiha-Lotta Jerevall
    Karl Hammar
    Birgit Olsson
    Bo Nordenskjöld
    Agneta Jansson
    Olle Stål
    Breast Cancer Research and Treatment, 2008, 108 : 35 - 41
  • [24] A homozygous missense variant in HSD17B4 identified in a consanguineous Chinese Han family with type II Perrault syndrome
    Chen, Kui
    Yang, Ke
    Luo, Su-Shan
    Chen, Chen
    Wang, Ying
    Wang, Yi-Xuan
    Li, Da-Ke
    Yang, Yu-Jie
    Tang, Yi-Lin
    Liu, Feng-Tao
    Wang, Jian
    Wu, Jian-Jun
    Sun, Yi-Min
    BMC MEDICAL GENETICS, 2017, 18
  • [25] FoxA2 and p53 regulate the transcription of HSD17B1 in ovarian granulosa cells of pigs
    Yuan, Xiaolong
    Zhou, Xiaofeng
    Qiao, Xiwu
    Wu, Qi
    Yao, Zhixiang
    Jiang, Yao
    Zhang, Hao
    Zhang, Zhe
    Wang, Xilong
    Li, Jiaqi
    REPRODUCTION IN DOMESTIC ANIMALS, 2021, 56 (01) : 74 - 82
  • [26] Comparison of Placental HSD17B1 Expression and Its Regulation in Various Mammalian Species
    Yazawa, Takashi
    Islam, Mohammad Sayful
    Imamichi, Yoshitaka
    Watanabe, Hiroyuki
    Yaegashi, Kazuhide
    Ida, Takanori
    Sato, Takahiro
    Kitano, Takeshi
    Matsuzaki, Shigenori
    Umezawa, Akihiro
    Muranishi, Yuki
    ANIMALS, 2023, 13 (04):
  • [27] HSD17B1 genetic variants and hormone receptor-defined breast cancer
    Gaudet, Mia M.
    Chanock, Stephen
    Dunning, Alison
    Driver, Kristy
    Brinton, Louise A.
    Lissowska, Jolanta
    Peplonska, Beata
    Pharoah, Paul
    Garcia-Closas, Montserrat
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (10) : 2766 - 2772
  • [28] POLYMORPHISMS IN THE CYP2C19 AND HSD17B1 GENES ASSOCIATED TO ESTROGEN METABOLISM IN WOMEN WITH ENDOMETRIOSIS
    Santos, A. A.
    Sonnewend, A.
    Mafra, F. A.
    Bianco, B. A. V.
    Barbosa, C. P.
    Christofolini, D. M.
    FERTILITY AND STERILITY, 2013, 100 (03) : S363 - S363
  • [29] The association between CYP17A1, CYP19A1, and HSD17B1 gene polymorphisms of estrogen synthesis pathway and ovarian cancer predisposition
    Kumar, G. Gowtham
    Paul, Solomon F. D.
    Molia, Chirag
    Manickavasagam, M.
    Ramya, R.
    Rani, G. Usha
    Ganesan, Nalini
    Mary, F. Andrea
    META GENE, 2022, 31
  • [30] Lepidiline A Improves the Balance of Endogenous Sex Hormones and Increases Fecundity by Targeting HSD17B1
    Cheng, Chuanjing
    Shen, Fukui
    Ding, Guoyu
    Liu, Aina
    Chu, Simeng
    Ma, Yuejiao
    Hou, Xiaotao
    Hao, Erwei
    Wang, Xiaoying
    Hou, Yuanyuan
    Bai, Gang
    MOLECULAR NUTRITION & FOOD RESEARCH, 2020, 64 (10)